Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes

Journal of Investigative Dermatology

Volumn 111, Issue 6, 1998, Pages 1140-1144

  Hoffman, Richard ^a   Starkey, Sue ^a   Coad, Jane ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Angiogenesis; Keratinocyte migration; Wound healing

Indexed keywords

1,10 PHENANTHROLINE; ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; BENZYLSULFONYL FLUORIDE; LEUKOCYTE ELASTASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; PLASMIN; PLASMINOGEN; SERINE PROTEINASE INHIBITOR;

AGED; ARTICLE; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME INHIBITION; FEMALE; HUMAN; KERATINOCYTE; LEG ULCER; MALE; PRIORITY JOURNAL;

EID: 0032448268     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00429.x     Document Type: Article

References (24)

1. Bradford MM: A refined and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
2. Cao Y, Ji RW, Davidson D, et al: Kringle domains of human angiostatin: characterisation of the antiproliferative activity on endothelial cells. J Biol Chem 271:29461-29467, 1996
3. Castillo MJ, Nakajima K, Zimmerman M, Powers JC: Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal Biochem 99:53-64, 1979
4. Dong Z, Kumar R, Yang X, Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88:801-810, 1997
5. Falanga V: Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 100:721-725, 1993
6. Gately S, Twardowski P, Stack MS, et al: The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 94:10868-10872, 1997
7. Grinnell F, Zhu M: Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α-proteinase inhibitor, and α2-macroglobulin. J Invest Dermatol 106:335-341, 1996
8. Kolev K, Lerant I, Tenekejiev K, Machovich R: Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors. J Biol Chem 269:17030-17034, 1994
9. Madri JA, Sankar S, Romanic AM: Angiogenesis. In: Clark RAF (ed.). The Molecular and Cellular Biology of Wound Repair. New York and London: Plenum Press, 1996, pp. 355-371
10. Mignatti P, Rifkin DB, Welgus HG, Parks WC: Proteinases and tissue remodelling. In: Clark RAF (ed.). The Molecular and Cellular Biology of Wound Repair. New York and London: Plenum Press, 1996, pp. 427-474
11. Miles LA, Dahlberg CM, Plow EF: The cell-binding domains of plasminogen and their function in plasma. J Biol Chem 263:11928-11934, 1988
12. O'Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994
13. O'Reilly MS, Holmgren L, Chen C, Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2:689-692, 1996
14. Patterson BC, Sang QXA: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272:28823-28825, 1997
15. Presta M, Maier JAM, Rusnati M, Ragnotti G: Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells. J Cell Physiol 141:517-526, 1989
16. Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT: α1-Antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105:572-578, 1995
17. Redini F, Tixier JM, Petitou M, Choay J, Robert L, Hornebeck W: Inhibition of leucocyte elastase by heparin and its derivatives. Biochem J 252:515-519, 1988
18. Reinartz J, Link J, Todd RF, Kramer MD: The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT). Exp Cell Res 214:486-498, 1994
19. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med 2:287-292, 1996
20. Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one "mini-" plasminogen (MW, 38,000) by elastase-catalyzed-specific limited proteolysis. In: Davidson JF, Rowan RM, Samma MM, Desnoyers PC (eds). Progress in Chemical Fibrinolysis and Thrombolysis, Vol 3, New York: Raven Press, 1978
21. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg PJ: Generation of plasminogen by reduction and proteolysis of plasmin. J Biol Chem 272:20641-20645, 1997
22. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Kontinnen YT: Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106: 1119-1124, 1996
23. Wysocki AB, Staiano-Coico L, Grinnell F: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dennatol 101:64-68, 1993
24. Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK: Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 5:23-32, 1997